中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

肝内胆管癌多学科综合治疗优化选择

刘连新尹大龙   

  1. 中国科学技术大学附属第一医院(安徽省立医院)肝胆外科,安徽合肥 200036
  • 出版日期:2020-06-01 发布日期:2020-06-24

  • Online:2020-06-01 Published:2020-06-24

摘要: 肝内胆管癌(ICC)作为第二常见的肝脏恶性肿瘤,虽然R0根治性切除是首选的可治愈方法,但ICC诊断时仅12%~40%病人可获得手术根治的机会,手术后5年存活率也仅为25%~40%。通过辅助化疗和区域治疗降期后可使部分晚期ICC病人获得行根治性手术或肝移植的机会。靶向药物和免疫治疗作为有益的补充,对于有基因突变作用靶点的选择性病人可能会延长生存期。以肝胆外科为主,包含影像科、病理科、肿瘤化疗科、放疗科和介入科的多学科诊疗团队,通过多学科讨论模式,结合病人具体病情,采取个体化、综合化的治疗手段,才能使ICC病人获得最优化的治疗选择。

关键词: 肝内胆管癌, 肝移植, 肝切除, 多学科治疗

Abstract: Optimal management of multidisciplinary treatment for intrahepatic chaolangiocarcinoma        LIU Lian-xin, YIN Da-long. Department of Hepatobiliary Surgery, the First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230036, China
Corresponding author:LIU Lian-xin,,E-mail:liulx@ustc.edu.cn
Abstract    Intrahepatic cholangiocarcinoma(ICC)is the second most common hepatic malignancy. Although radical R0 resection is the preferred treatment,only about 12% to 40% of the patients with ICC have the chance of radical surgery at the time of diagnosis. Current 5-year overall survival following liver resection is in the range of 25% to 40%. For locally advanced disease not amenable to upfront liver resection,neoadjuvant chemotherapy or locoregional therapies may be used with the aim of converting those patients to resectability or even to transplantation in well-selected cases. Molecular profiling of ICC is likely to provide improved prognostic assessment,more precise selection for surgical intervention and objective stratification of risk of recurrence to be counteracted by specifically designed adjuvant treatments such as targeting molecular and immunotherapy. The multi-disciplinary treatment should mainly focus on hepatobiliary surgeon,including specialist from radiology,pathology,oncology,radiotherapy and interventional department. The optimal option for ICC can be employed only through multi-disciplinary management based on the patient's individualized presentations.

Key words: intrahepatic cholangiocarcinoma, liver resection, liver transplantation, multidisciplinary treatment